Emerging Safety Science Workshop Summary (2008) / Chapter Skim
Currently Skimming:
Appendix B: Speaker Biographies
Appendix B: Speaker Biographies
Pages 125-134
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 125... ...
She has authored 40 publications and served on the editorial board of the Drug Information Association Journal. She currently co-chairs the collaborative PhRMA–FDA working group for safety signal detection, and was lead author of its benchmark publication on quantitative signal detection.
|
From page 126... ...
He has been elected to the Association of American Physicians and has been awarded the Warner Lambert/Parke Davis Award by the American Association of Pathologists, the AAI-Huang Foundation Meritorious Career Award by the American Association of Immunologists, and an Outstanding Inventor Award from Stanford University. He received the Crafoord Prize from the Swedish Academy of Sciences in 2004 for the scientific discovery of mechanisms of leukocyte trafficking contributing to the treatment of arthritis and inflammatory diseases.
|
From page 127... ...
He received his DVM degree from Kansas State University in 1987 and a PhD in molecular biology from the University of Miami School of Medicine. He completed a residency and National Institutes of Health–funded fellowship in comparative pathology at the University of Miami Jackson Memorial Hospital in 1996 and served on the faculty of the University of Georgia College of Veterinary Medicine as assistant and associate professor of pathology prior to joining GSK.
|
From page 128... ...
Halbert, PhD, joined Iconix Biosciences in March 2005 as Executive Vice President of Research and Development. Iconix works with a wide range of pharmaceutical clients to apply gene expression profiling as well as biomarker discovery and validation to understanding mechanisms of drug toxicity and improving preclinical drug safety.
|
From page 129... ...
Halbert served on and chaired numerous biotechnology scientific collaboration committees and was head of the Abbott Corporate Genomics Task Force. Prior to joining Abbott, he held scientific and management positions at Becton Dickinson in molecular biology and diagnostics, and was a cofounder of the molecular diagnostics company Gene-Trak Systems in Framingham, Massachusetts.
|
From page 130... ...
He is board certified in neurology, and is a former member of the board of directors of the National Sleep Foundation, a member of the Board of Directors of the Delaware Valley Science Fairs, a member of the University of Pennsylvania Center for Bioethics Advisory Board, and a past trustee of the American Academy of Pharmaceutical Physicians. Eric Lai, PhD, is Vice President of Pharmacogenetics (PGx)
|
From page 131... ...
He is a member of the Association of American Medical Colleges Advisory Panel on Research and the Institute of Medicine's Roundtable on Evidence Based Medicine, and he currently chairs the FDA's Drug Safety and Risk Management Advisory Committee. He chaired the Executive Committee of the HMO Research Network, was co-chair of the Board of Scientific Counselors of the Centers for Disease Control and Prevention's (CDC's)
|
From page 132... ...
Brian B Spear, PhD, is Research Director within Abbott Laboratories' Global Pharmaceutical Research and Development Division, with responsibility for genomics, pharmacogenetics, cell and molecular toxicology, and bioinformatics.
|
From page 133... ...
Weinberger, PhD, is a biomedical scientist with particular expertise in metabolomics, infectious diseases, public health, and immunology, and serves as Chief Scientific Officer and member of the management board for BIOCRATES Life Sciences. Before joining BIOCRATES in January 2003, he led a research group specializing in clinical virology, infection immunology, and molecular epidemiology at the Institute for Medical Microbiology and Hygiene at the University of Regensburg, Germany.
|
From page 134... ...
She previously served in other positions at the agency, including Director, Office of Therapeutics Research and Review, and Acting Deputy Director, Center for Biologics Evaluation and Research.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.